However, a published expert review of the Phase 2 data in Expert Opinion on Investigational Drugs (2023) noted: "Heart rate was increased by up to 6.7 beats/min by retatrutide, which may be detrimental and offset some of the benefits of weight loss" particularly for patients with cardiovascular comorbidities
Enfermedad cardiovascular aterosclertica: estudios observacionales han generado debate sobre si la produccin intestinal de trimetilamina a partir de carnitina podra contribuir al riesgo cardiovascular en personas con microbiota susceptible
In an engaging YouTube discussion with podcaster Chris Williamson, he delves deep into these topics, offering valuable advice on balancing muscle gain with fat loss
Consequently, patients with T2DM often exhibit reduced Pdx1 expression levels (Ofori et al., 2022)
This triggers the gastrocolic reflex, a natural response where stomach filling signals the colon to make room by initiating a bowel movement
Lack of Clinical Data : The safety and efficacy data supporting tirzepatide use come exclusively from studies using FDA-approved formulations